APA (7th ed.) Citation

Hashmi, A. A., Ajaz, Y., Sajjad, M., Zia, F., Irfan, M., Bakar, S. M. A., . . . Faridi, N. Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers. Wiley.

Chicago Style (17th ed.) Citation

Hashmi, Atif Ali, Yumna Ajaz, Muhsana Sajjad, Fazail Zia, Muhammad Irfan, Syed Muhammad Abu Bakar, Erum Yousuf Khan, and Naveen Faridi. Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers. Wiley.

MLA (9th ed.) Citation

Hashmi, Atif Ali, et al. Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers. Wiley.